arrow
R

Richard H. Wilson

university of glasgow
H指数:62
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance

MAPK驱动的上皮细胞可塑性驱动结直肠癌治疗抵抗

Nature
IF48.5
2025-11-240
PRE
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial

FOLFIRINOX或FOLFOX用于局部晚期或转移性小肠腺癌:PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA II期随机试验

2025-07-280
OAAI
Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) plus bevacizumab vs FOLFIRI plus bevacizumab for the second-line treatment of patients with advanced/metastatic colorectal cancer (NuTide:323)
2023-12-010
PRE
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial

癌症患者中血栓素的生物合成及其受阿司匹林抑制:Add-Aspirin试验的一项子研究

2023-07-0713
OA
Dataset for Pathology Reporting of Colorectal Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)

结直肠癌病理报告数据集:国际癌症报告协作组织(ICCR)的建议

2021-07-0734
OAAI
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

靶向核苷酸代谢增强蒽环类药物和抗代谢物在三阴性乳腺癌中的疗效

2021-04-0611
OAAI
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
2019-11-0156
OAAI